• AIHealthTech Insider
  • Posts
  • 😄“Laughing Gas” Works Faster Than Antidepressants - But There’s a Catch

😄“Laughing Gas” Works Faster Than Antidepressants - But There’s a Catch

INSIDE: Cataract Robotics • AF Watches • Aortic AI • Seizure AI • Bone Loss

In partnership with

AIHealthTech Insider: Issue #78

December 8, 2025

This week’s snapshot? Micro-precision robots completing cataract surgeries. Wearables predicting seizures. AI reading aortas in seconds. Smartwatches flagging AF with near-clinical accuracy. Even laughing gas showing fast- if brief - antidepressant effects.

Across ophthalmology, cardiology, neurology, and radiology, the theme is clear:
diagnostics are becoming predictive, workflows are becoming automated, and clinical decisions are becoming faster and more data-driven.

Summaries are for education, not medical advice. Always verify locally before clinical use.

A UCLA-engineered surgical robot just completed the world’s first human robotic cataract procedures, delivering micro-precision (0.053 mm) and consistent intraocular control across 10 patients.

Image Source: Ideogram/AIHealthTech Insider

Why it matters

  • Enables highly stable corneal incisions + lens extraction

  • Reduces variability in delicate micron-level steps of cataract surgery

  • Opens the door to fully robot-assisted ophthalmic procedures

A JACC: Advances meta-analysis of 26 studies (17,000+ patients) shows smartwatch AF detection has ~95% sensitivity and ~96% specificity. PPG- and single-lead ECG devices performed similarly, but real-world PPV may decrease in low-prevalence populations due to heterogeneity and small-study effects.

Image Source: Ideogram/AIHealthTech Insider

Why it matters

  • Continuous wrist-based rhythm surveillance can rival traditional ECG and Holter for AF detection

  • High NPV makes a normal tracing on a validated device reassuring in many scenarios

  • False positives and low-burden AF episodes risk overtreatment—screening still needs CHA₂DS₂-VASc–guided, individualized decisions

Sponsored

Want to get the most out of ChatGPT?

ChatGPT is a superpower if you know how to use it correctly.

Discover how HubSpot's guide to AI can elevate both your productivity and creativity to get more things done.

Learn to automate tasks, enhance decision-making, and foster innovation with the power of AI.

A systematic review of 7 trials (n=247) finds inhaled N₂O (25–50%) produces fast symptom drops in MDD/TRD/BP depression within 2–24 hours, with effects largely waning by 1 week.

Image Source: Ideogram/AIHealthTech Insider

Why it matters

  • NMDA-modulating, ketamine-adjacent option with mostly mild, transient AEs (nausea, dizziness, headache)

  • Repeated 50% N₂O sessions show higher response/remission vs placebo, but durability and optimal dose remain unclear

  • Evidence base still early-phase: small samples, heterogeneous dosing, limited long-term and adolescent/BP data

RapidAI's FDA-cleared Aortic Management tool uses AI to measure, reconstruct, and track the aorta from any CT scan, providing accurate metrics and 3D models instantly. This reduces reading time and aids in early detection during long-term surveillance.

Image Source: RapidAI

Why it matters

  • Automates complex aortic measurements to cut cognitive load

  • Standardizes reporting and reduces inter-reader variability

  • Longitudinal tracking supports earlier, potentially life-saving intervention

  • Works across routine, acute, and post-treatment CT — expanding real-world use

Sponsored

Learn AI in 5 minutes a day

What’s the secret to staying ahead of the curve in the world of AI? Information. Luckily, you can join 1,000,000+ early adopters reading The Rundown AI — the free newsletter that makes you smarter on AI with just a 5-minute read per day.

Neuraxpharm and mjn-neuro have launched EPISERAS, a CE-marked Class IIa wearable that predicts epileptic seizures in real time. The headset monitors brain activity continuously and uses AI models to generate risk alerts through a companion mobile app.

Image Source: Ideogram/AIHealthTech Insider

Why it matters

  • Advance warnings improve safety, autonomy, and daily functioning

  • Remote seizure-pattern tracking reduces in-clinic monitoring needs

  • Marks a shift from detection to proactive, AI-driven neurological prevention

A Bone Research review shows that rapid or sustained weight loss from illness, GLP-1 drugs, or bariatric surgery can reduce bone mineral density, damage micro-architecture, and increase fracture risk due to reduced mechanical loading, hormonal changes, marrow fat gain, under-nutrition, and altered energy metabolism.

Image Source: Ideogram/AIHealthTech Insider

Why it matters

  • Reframes weight loss as a potential skeletal risk, not just a metabolic win

  • Explains why hips and cortical bone are hit hardest in dieting, CR, and surgery

  • Flags the need for bone monitoring, nutrition, and strength training alongside weight-loss therapies

Sponsored

Wall Street’s Morning Edge.

Investing isn’t about chasing headlines — it’s about clarity. In a world of hype and hot takes, The Daily Upside delivers real value: sharp, trustworthy insights on markets, business, and the economy, written by former bankers and seasoned financial journalists.

That’s why over 1 million investors — from Wall Street pros to Main Street portfolio managers — start their day with The Daily Upside.

Invest better. Read The Daily Upside.

💡 The Real Question: Where Should AI Go Solo First?

Image Source: Ideogram/AIHealthTech Insider

Over the next 3 years, which clinical task is safest to let AI handle mostly unsupervised? Vote below.

Login or Subscribe to participate in polls.

Stay Ahead: AI Healthcare News!

This is just a glimpse of the AI healthcare revolution. Subscribe for exclusive updates on medicine’s future!